Scientific and Official Sources PubChem: BPC-157 identity, synonyms, molecular formula and mass Sikiric and colleagues: early published BPC-157 research ClinicalTrials.gov: PCO-02 BPC-157 safety and pharmacokinetics study Lee and colleagues: two-participant BPC-157 intravenous pilot study McGuire and colleagues: narrative review of BPC-157 evidence and risk World Anti-Doping Agency: 2026 Prohibited List MHRA: Borderline products and how to tell if a product is a medicine Human Medicines Regulations 2012: Regulation 279 United States FDA: safety risks associated with certain bulk substances, including BPC-157 United States FDA: BPC-157-related bulk-substance briefing document CAP Code Section 12: Medicines and health-related products Health and Safety Executive: UK REACH Health and Safety Executive: Safety Data Sheets and COSHH Health and Safety Executive: COSHH risk assessment Cox and colleagues: identification and analytical detection of BPC-157 in confiscated material
trial data do not describe product data
Additionally, individuals experiencing certain neurological symptoms or those with high levels of homocysteine, a risk factor for cardiovascular diseases, might find our B12 injections beneficial
User protocols mirror tendon approaches with 0.25 to 0.5 mg daily for six to eight weeks minimum
Short-Term Effects (Days to Weeks): Improved energy levels: Typically within 48 to 72 hours, patients may notice increased energy and reduced fatigue
Used by nearly a quarter of adults globally, meds such as omeprazole are used to reduce stomach acid levels, but consistent use for 12 months or more can lower B12 absorption
